National Comprehensive Cancer Network

Educational Events & Programs

NCCN 20th Annual Conference:
Advancing the Standard of
Cancer Care™

March 12 – 14, 2015
(Pre-conference programs to take place on
Wednesday, March 11, 2015)

The Diplomat
Hollywood, Florida



Early bird deadline is Monday, February 2, 2015!
Receive $100 off registration fee.

Overview

The NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the data upon which the NCCN Guidelines® are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas.


Wednesday, March 11, 2015*

The following pre-conference programs requiring separate registration are scheduled for
Wednesday, March 11.

2015 NCCN Nursing Program:
Advancing Oncology Nursing™
Wednesday, March 11, 2015 • 8:00 AM – 3:00 PM

This educational event has reached maximum capacity. All registrants from this point on will be placed on a wait-list and will be contacted if a seat becomes available. We encourage you to register and attend the main conference.

Register Now!Early bird deadline is Monday, February 2, 2015!
NCCN Academy for Excellence & Leadership in Oncology™
School of Pharmaceutical & Biotech Business
Wednesday, March 11, 2015 • 8:20 AM – 2:15 PM

(CME/CE credits are not available for this program.)

Thursday, March 12, 2015*

7:00 – 8:15 AM
Breakfast, Exhibits, and General Poster Session I (Exhibition Hall)

8:15 – 8:25 AM
Welcome and Opening Remarks
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

8:25 – 9:10 AM
Keynote Address: 20 Years of Improving the Quality, Effectiveness,
and Efficiency of Cancer Care
(CME/CE credits are not available for this session)
Robert W. Carlson, MD
Chief Executive Officer
National Comprehensive Cancer Network

9:10 – 9:20 AM
Break, Exhibits, and General Poster Session I (Exhibition Hall)

New for 2015! Customize Your Learning with Track Sessions

9:20 – 10:20 AM Track › choose one
Breakout Room A:
Advances in Management of Early Stage Breast Cancer

Amy Cyr, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Breakout Room B:
Diagnosis and Treatment of NSCLC Using Minimally Invasive Techniques

Thomas A. D'Amico, MD
Duke Cancer Institute

Breakout Room C:
Treatment Milestones in CML: Stay the Course or Change Therapy?

Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

10:20 – 10:45 AM
Break, Exhibits, and General Poster Session I (Exhibition Hall)

10:45 – 11:45 AM Track › choose one
Breakout Room A:
Optimizing Treatment of HER2-Positive Breast Cancer

William J. Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Breakout Room B:
Role of Radiation Therapy in Management of SLC
John C. Grecula, MD
The Ohio State University Comprehensive
Cancer Center - James Cancer Hospital
and Solove Research Institute

Breakout Room C:
Updates to the Management of CLL
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

11:45 AM – 1:00 PM
Lunch Break, Exhibits, and General Poster Session I (Exhibition Hall)

New for 2015! An NCCN Commemorative Event

1:00 – 2:20 PM
20 Years of Improving Cancer Care Together – An NCCN Roundtable Discussion
Moderated by: Clifford Goodman, PhD, The Lewin Group

In recognition of NCCN’s 20th Anniversary, this special live Roundtable will be comprised of NCCN leadership – past and present– as well as other stakeholders who have had a significant impact on the development, progression, and success of NCCN over the years; noteworthy historical NCCN accomplishments and events will be discussed, as well as the impact NCCN has had and continues to have on the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. This special 20th Anniversary Roundtable will be filmed and endured on NCCN.org.

This roundtable is sponsored by AbbVie; Hologic; ImmunoGen, Inc.; Incyte Corporation; Merck Sharp & Dohme Corp.; and Sigma-Tau Pharmaceuticals, Inc.
As of January 21, 2015

(CME/CE credits are not available for this session.)

Sponsorship opportunities are available for this roundtable. Please send an e-mail to exhibits@nccn.org.

2:20 – 2:30 PM
Break and Exhibits (Exhibition Hall)

New for 2015! Customize Your Learning with Track Sessions

2:30 – 3:30 PM Track › choose one
Breakout Room A:
Treatment Options for Advanced Melanoma
John A. Thompson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Breakout Room B:
Optimizing Systemic Therapy Selection in Metastatic Colorectal Cancer
Axel Grothey, MD
Mayo Clinic Cancer Center

Breakout Room C:
New Treatment Options in Castration-Recurrent Prostate Cancer
Andrew J. Armstrong, MD, ScM
Duke Cancer Institute

3:30 – 3:45 PM
Break and Exhibits (Exhibition Hall)

3:45 – 4:45 PM Track › choose one
Breakout Room A:
Management of Dermatologic Toxicities Associated with Targeted Therapies
Mario E. Lacouture, MD
Memorial Sloan Kettering Cancer Center

Breakout Room B:
Multidisciplinary Management of Pancreatic Cancer
Margaret A. Tempero, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Breakout Room C:
Kidney Cancer: Current and Novel Treatment Options
Eric Jonasch, MD
The University of Texas
MD Anderson Cancer Center

4:45 – 5:30 PM
Free Time

Returning in 2015! An NCCN Commemorative Event

5:30 – 7:30 PM
Welcome Reception
Join NCCN for a reception in celebration of our 20th anniversary.

Friday, March 13, 2015*

7:00 – 8:15 AM
Breakfast, Exhibits, and General Poster Session II (Exhibition Hall)

8:15 – 9:45 AM
Roundtable:
Value-Based Decision-Making at the Bedside
Moderated by: Clifford Goodman, PhD, The Lewin Group

9:45 – 10:00 AM
Break, Exhibits, and General Poster Session II (Exhibition Hall)

New for 2015! Customize Your Learning with Track Sessions

10:00 – 11:00 AM Track › choose one
Breakout Room A:
Management of Localized Melanoma
Daniel G. Coit, MD
Memorial Sloan Kettering Cancer Center

Breakout Room B:
Endoscopic Therapies for Early Stage Esophageal Cancers
Hans Gerdes, MD
Memorial Sloan Kettering Cancer Center

Breakout Room C:
Guideline Update in the Management of Bladder Cancer
Peter E. Clark, MD
Vanderbilt-Ingram Cancer Center

11:00 – 11:15 AM
Break, Exhibits, and General Poster Session II (Exhibition Hall)

11:15 – 12:15 PM
Making NCCN Guidelines Relevant Around the Globe:
The Challenge of Resource Stratification
Benjamin O. Anderson, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Wui-Jin Koh, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

12:15 – 1:30 PM
Lunch Break, Exhibits, and General Poster Session II (Exhibition Hall)

1:30 – 2:30 PM
Principles of Immunotherapy (Part I)
Anthony J. Olszanski, MD, RPh
Fox Chase Cancer Center

2:45 – 3:45 PM Track › choose one
Breakout Room A:
Evolving Treatment Strategies for Triple Negative Breast Cancer
Melinda Telli, MD
Stanford Cancer Institute

Breakout Room B:
Targeted/Emerging Therapies for Metastatic NSCLC
Leora Horn, MD, MSc
Vanderbilt-Ingram Cancer Center

Breakout Room C:
Multiple Myeloma: Current Treatment Approaches and Future Directions
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center

4:00 – 5:00 PM Track › choose one
Breakout Room A:
Fertility Preservation and Cancer: Current and Future Strategies

Breakout Room B:
New NCCN Guidelines: Smoking Cessation for Patients with Cancer

Peter G. Shields, MD
The Ohio State University Comprehensive
Cancer Center – James Cancer Hospital
and Solove Research Institute

Breakout Room C:
Management of Anthracycline-Induced Cardiac Toxicity: Emphasis on Early Recognition and Management in the Cancer Survivor
Crystal S. Denlinger, MD
Fox Chase Cancer Center

Saturday, March 14, 2015*

7:00 – 8:15 AM
Breakfast

8:15 – 9:45 AM
Roundtable: What are the Characteristics of an Optimal Clinical Practice Guideline?
Moderator: F. Marc Stewart, MD, Fred Hutchinson Cancer Research Center/
Seattle Cancer Care Alliance

9:45 – 9:55 AM
Break

9:55 – 10:55 AM
Adjuvant Therapy for NSCLC
Gregory A. Otterson, MD
The Ohio State University Comprehensive
Cancer Center – James Cancer Hospital
and Solove Research Institute

11:00 AM – 12:00 PM
New Therapies for Hormone-Sensitive Advanced Breast Cancer
Ingrid A. Mayer, MD, MSCI
Vanderbilt-Ingram Cancer Center

12:00 – 12:45 PM
Lunch Break

12:45 – 1:45 PM
Emerging Treatment Options for B-cell Lymphomas
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

1:50 – 2:50 PM
Immunotherapy for Melanoma, Kidney, and Prostate Cancers (Part II)
Eric Jonasch, MD
The University of Texas
MD Anderson Cancer Center

Anthony J. Olszanski, MD, RPh
Fox Chase Cancer Center

*Subject to change.


Supporters:

This conference is supported by educational grants from Actelion; AstraZeneca; Bristol-Myers Squibb; BTG International; Celgene Corporation; Genentech BioOncology; Gilead Sciences, Medical Affairs; Lilly; Millennium: The Takeda Oncology Company; and Pfizer.

This activity was made possible by Pharmacyclics, Inc. and Janssen Biotech, Inc.

As of December 15, 2014


Exhibitor Information

Exhibition Hall Floor Plan
Exhibitor Show Services Kit
Exhibit Application
Advertising Rate Card
Reimbursement Resource Room Application and Contract

Organizations who are interested in exhibits or sponsorships are encouraged to send an e-mail to exhibits@nccn.org


Future NCCN Annual Conference Dates:

  • Thursday, March 31, 2016 – Saturday, April 2, 2016
    Pre-conference programs take place on Wednesday, March 30, 2016